|
|
|
|
|
|
|
|
|
|
| New Cancer Case (Incidence) Rates — Oklahoma vs. United States,* 2004, Male and Female
|
|
|
Age-adjusted Rates per 100,000‡
Example: For every 100,000 men and women in Oklahoma, on average, approximately 18.7 were diagnosed with non-hodgkin lymphoma cancer. For every 100,000 men and women in the United States, on average, approximately 19.0 were diagnosed with non-hodgkin lymphoma cancer.
|
|
Visit United States Cancer Statistics
for more information on top cancer sites by geographic area, race, and gender.
Glossary
Footnotes * Data are from selected statewide and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See registry-specific data quality information. Rates cover approximately 98% of the U.S. population. † Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. ‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups — Census P25–1130). See Table 2.1.1.1MF-2.27.1.1MF for 95% confidence intervals for rates. Rates are suppressed and not ranked if case counts are fewer than 16 or if the population of the specific category (area, sex) is less than 50,000. Notes: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Urinary bladder cases include invasive and in situ.
|
|
